Skip to main content
. 2020 Aug;48(8):645–654. doi: 10.1124/dmd.120.090696

TABLE 1.

Kinetic parameters (mean ± S.D.) describing metabolism of amodiaquine and midazolam in HLM suspensions and HLM-MGBS

Parameter Amodiaquine (CYP2C8) Midazolam (CYP3A)
HLMSI HLM-MGBSSI HLMMM HLM-MGBSSI
Km (µM) 0.732 ± 0.11 1.21 ± 0.08ns 0.612 ± 0.086 2.04 ± 0.23sig
Vmax (pmol/min per milligram) 982 ± 89 1030 ± 87ns 2002 ± 66 4350 ± 249sig
CLint (µl/min per milligram) 1341 851 2828 2132

MM, Michaelis-Menten modeling used; ns, not significantly different from parameter generated using HLM; SI, substrate inhibition modeling used; sig, significantly different from parameter generated using HLM (P < 0.05).